|
MK-4208 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: HS-10382, Tern-701
Pipeline
Phase 1/2: 1
Top Sponsors
- Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Indications
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
- Chronic Myeloid Leukemia, Chronic Phase1
- Chronic Myeloid Leukemia1
- Cancer1
Birmingham, Alabama1 trial
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
University of Alabama Medicine (UAB Medicine)
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.